Hypothesized cause of delayed hemolysis associated with intravenous artesunate

Medical Hypotheses

Volumn 82, Issue 2, 2014, Pages 167-170

  Clark, Robert L ^a  

^a Artemis Pharmaceutical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; HEMOGLOBIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED HEMOLYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EMBRYOTOXICITY; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN CELL; HYPOTHESIS; MALARIA; NONHUMAN; RAT; RETICULOCYTE; RETICULOCYTOPENIA; SINGLE DRUG DOSE;

ARTESUNATE;

ADMINISTRATION, INTRAVENOUS; ANEMIA; ANEMIA, HEMOLYTIC; ANIMALS; ANTIMALARIALS; ARTEMISININS; ERYTHROCYTES; HAPLORHINI; HEMOGLOBINS; HEMOLYSIS; HUMANS; MALARIA; RATS; RETICULOCYTES; TIME FACTORS;

EID: 84892371058     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.11.027     Document Type: Article

References (23)

1. Angus B.J., Chotivanich K., Udomsangpetch R., White N.J. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 1997, 90:2037-2040.
2. Binh T.Q., Ilett K.F., Batty K.T., Davis T.M.E., Hung N.C., Powell S.M., et al. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol 2001, 51(6):541-546.
3. Chotivanich K., Udomsangpetch R., Dondorp A., Williams T., Angus B., Simpson J.A., et al. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis 2000, 182:629-633.
4. Clark R.L. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Repro Tox 2009, 28:285-296.
5. Clark R.L. Effects of artemisinins on reticulocyte count and relationship to possible embryotoxicity in confirmed and unconfirmed malarial patients. Birth Defects Res A Clin Mol Teratol 2012, 94:61-75.
6. Clark R.L., Lerman S.A., Cox E.M., White T.E. Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes and relationship to reticulocyte count. Birth Defects Res B 2008, 83:397-406.
7. Clark R.L., Gristwood W.E., Lewsley R., Wilson R., Harrell A.W. Localization of artesunate and its derivatives in the pregnant rat and fetus following oral administration and relationship to developmental toxicity. Birth Defects Research, Part B 2010, 89:364-375.
8. Corpolongo A., De Nardo P., Ghirga P., Gentilotti E., Bellagamba R., Tommasi C., et al. Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine. Malar J 2012 Mar, 27(11):91.
9. Gu H.M., Warhurst D.C., Peters W. Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1984, 78(2):265-270.
10. Haldar K., Mohandas N. Malaria, erythrocytic infection, and anemia. Hematology Am Soc Hematol Educ Program 2009, 87-93.
11. Knights, P. Artesunate: 14day preliminary oral (gavage administration) toxicity study in the rat. Covance report No. 1552/051-D6154. 2002a.
12. Knights, P. Artesunate: 4week oral (gavage administration) toxicity study in the rat. Covance report No. 1552/059-D6154. 2002b.
13. Lamikanra A.A., Brown D., Potocnik A., Casals-Pascual C., Langhorne J., Roberts D.J. Malarial anemia: of mice and men. Blood 2007, 110:18-28.
14. Mercer A.E., Maggs J.L., Sun X.M., Cohen G.M., Chadwick J., O'Neill P.M., et al. Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem 2007, 282(13):9372-9382.
15. Phillips R.E., Looareesuwan S., Warrell D.A., Lee S.H., Karbwang J., Warrell M.J., et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986, 58:305-323.
16. Posobiec LM, Clark RL, Bushdid PB, Laffan SB, Wang K, White TE. Dihydroartemisinin (DHA) treatment causes an arrest of cell division and apoptosis in rat embryonic erythroblasts in whole embryo culture. Birth Defects Res B, 2013; in press.
17. Rolling T., Schmiedel S., Wichmann D., Wittkopf D., Burchard G.D., Cramer J.P. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J 2012 May, 17(11):169.
18. Teja-Isavadharm P., Watt G., Eamsila C., Jongsakul K., Li Q., Keeratithakul G., et al. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria. Am J Trop Med Hyg 2001, 65(6):717-721.
19. Teja-lsavadharm P, Apollo D. Siriyanonda D,Lim A, Wannaying S, Miller R, Weina P, Fukuda M, Polhemus M, Remich S. Pharmacokinetic analysis of artesunate and dihydroartemisinin in plasma following administration of an I.V. ICH cGMP formulation of artesunate to patients with uncomplicated falciparum malaria, Annual Meeting of the American Society of Tropical Medicine and Hygiene, 2007.
20. Turgeon M.L. Clinical hematology: theory and procedures 2005, Lippincott Williams & Wilkins, Philadelphia, 570. 4th edition.
21. Weina P.J., Haeberle A.S., Milhous W.K. Intravenous artesunate: the new generation of lifesaving treatment for severe malaria in the warfighter 2006, Walter Reed Army Inst of Research, Silver Spring, Maryland.
22. Zhang H., Wu Y., Wang L., Xu H. Study on mitochondria pathway of apoptosis induced by artesunate and thermotherapy in A549 cell line. Zhongguo Gonggong Weisheng 2009, 25(6):699-701.
23. Zoller T., Junghanss T., Kapaun A., Gjorup I., Richter J., Hugo-Persson M., et al. Intravenous artesunate for severe malaria in travelers. Europe Emerg Infect Dis 2011 May, 17(5):771-777.